Seagen Inc.
ADCS WITH THIOL MULTIPLEX LINKERS

Last updated:

Abstract:

The present disclosure provides, inter alia, thiol multiplexed Antibody Drug Conjugates (TM-ADCs) and Multiplex Linking Assemblies (MLAs) that comprise multiple Drug Moieties in a single linking assembly.

Status:
Application
Type:

Utility

Filling date:

20 Dec 2019

Issue date:

10 Feb 2022